L3VLUP
ProSign in

CRSP in the 13F filings

Crispr Therapeutics AG · CUSIP H17182108

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Dec 2025
the date the book describes
Filed
19 Feb 2026
latest of these filings; the earliest 10 Feb 2026
Managers listing it
19
at least, of 95 tracked, among listed positions
Comparable managers
92
filed both Q3 2025 and Q4 2025; 3 listed it in both
Shares listed
15,259,353
combined, among listed positions
Reported value
$800m
combined, at the quarter end

Among the 92 comparable managers: 11 buyers (opened or added shares) and 9 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +372,780.

Managers listing CRSP in Q4 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

19 of 19 holders

ActionFiling
ARK Investment Management LLC10,522,057$552m3.66%Added+735,08411 Feb 2026 (the filing on sec.gov)
Fidelity (FMR LLC)1,953,957$102munder 0.1%Added+68,29417 Feb 2026 (the filing on sec.gov)
Susquehanna International Group LLP853,971$45munder 0.1%Added+39,64717 Feb 2026 (the filing on sec.gov)
Squarepoint Ops LLC581,108$30munder 0.1%Newnew13 Feb 2026 (the filing on sec.gov)
Two Sigma Investments LP470,621$25munder 0.1%Trimmed-574,06817 Feb 2026 (the filing on sec.gov)
Citadel Advisors LLC267,685$14munder 0.1%Added+100,58417 Feb 2026 (the filing on sec.gov)
Two Sigma Advisers LP162,400$8.5munder 0.1%Trimmed-410,57217 Feb 2026 (the filing on sec.gov)
AllianceBernstein LP96,357$5.1munder 0.1%Added+10,02317 Feb 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc84,940$4.5munder 0.1%Added+8,40517 Feb 2026 (the filing on sec.gov)
Invesco Ltd60,796$3.2munder 0.1%Trimmed-4,53119 Feb 2026 (the filing on sec.gov)
Tudor Investment Corp39,468$2.1munder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Janus Henderson Group Ltd34,774$1.8munder 0.1%Held017 Feb 2026 (the filing on sec.gov)
Wellington Management Group LLP34,072$1.8munder 0.1%Trimmed-2,41417 Feb 2026 (the filing on sec.gov)
Millennium Management LLC30,492$1.6munder 0.1%Trimmed-55,79017 Feb 2026 (the filing on sec.gov)
Balyasny Asset Management LLC21,202$1.1munder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
AQR Capital Management LLC20,746$1.1munder 0.1%Trimmed-7,62617 Feb 2026 (the filing on sec.gov)
Verition Fund Management LLC13,934$731kunder 0.1%Trimmed-10,84413 Feb 2026 (the filing on sec.gov)
Man Group PLC8,589$450kunder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Quantbot Technologies LP2,184$115kunder 0.1%Newnew10 Feb 2026 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2025 to Q4 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (5)

Exited (2)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
4 in Q3 2024 to 3 in Q2 2026

Tracked managers listing it, at least.

035810201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
CRSP by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20171$206kn.a.n.a.
Q3 20171$457kn.a.n.a.
Q4 20172$21mn.a.n.a.
Q1 20183$39mn.a.n.a.
Q2 20183$100mn.a.n.a.
Q3 20184$146mn.a.n.a.
Q4 20185$103mn.a.n.a.
Q1 20192$98mn.a.n.a.
Q2 20192$152mn.a.n.a.
Q3 20193$138mn.a.n.a.
Q4 20196$252mn.a.n.a.
Q1 20207$237mn.a.n.a.
Q2 20205$517mn.a.n.a.
Q3 20204$763mn.a.n.a.
Q4 20209$2.0bnn.a.n.a.
Q1 20214$1.3bnn.a.n.a.
Q2 20214$1.5bnn.a.n.a.
Q3 20214$903mn.a.n.a.
Q4 20214$781mn.a.n.a.
Q1 20226$696mn.a.n.a.
Q2 20226$799mn.a.n.a.
Q3 20225$603mn.a.n.a.
Q4 20226$369mn.a.n.a.
Q1 20234$380mn.a.n.a.
Q2 20236$483mn.a.n.a.
Q3 20234$354mn.a.n.a.
Q4 20234$609m23
Q1 20244$595m22
Q2 20245$480m32
Q3 20244$403m15
Q4 20242$388m21
Q1 20253$414m30
Q2 20254$643m40
Q3 20254$748m04
Q4 20251$552m119
Q1 20264$840m165
Q2 20263$883m158

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

CRSP and GILD →CRSP and AMGN →CRSP and ARGX →Choose a stock to compare with CRSP →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own CRSP, latest filings →Back to the 13F Explorer →